Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Clinical trial NCT02174978 · COMPLETED
Trial details
- NCT number
- NCT02174978
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.